Opus Genetics IRD
NASDAQ IRD
$4.27 +0.04 (+0.95%)
As of: Nov 11, 2026 · 11:53 AM EST

Opus Genetics (IRD) Total Debt (2019 - 2026)

Updated

Opus Genetics' Total Debt came in at $34.93 million for Q2 2026, compared with $1 million a year earlier.

Analysis

Opus Genetics (IRD) Total Debt (2019 - 2026) Analysis & Trends

At the end of FY2025, Opus Genetics' Total Debt was $1.13 million.

  • Total Debt carries a four-year compound annual growth rate of 20.4% (FY2021 to FY2025).
  • Going back by year, Total Debt was $538,000 in FY2021.
  • The Q2 2026 figure represents the highest quarterly Total Debt in data going back to Q4 2019.
  • Business Quant data shows IRD's Total Debt at $1.2 million (Q1 2026), $1.13 million (Q4 2025) and $1.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Opus Genetics 405.23 Mn 122.33 Mn - 34.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 34.53 Mn
Jun 30, 2026 34.93 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2022 215,000.00
Dec 31, 2021 538,000.00
Dec 31, 2019 4.98 Mn
API Access

Opus Genetics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IRD&period=max&api_key=YOUR_API_KEY